Transaction in Own Shares • Dec 17, 2025
Transaction in Own Shares
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 9975L
Victrex PLC
17 December 2025
Victrex plc (the Company) is an innovative world leader in high performance polymer solutions, delivering sustainable products which enable environmental and societal benefit in multiple end-markets. The Company announces that Ian Melling (Chief Financial Officer), has exercised share options over ordinary shares in the Company on 12 December 2025 granted under the Victrex 2019 Long Term Incentive Plan and the 2017 Deferred Bonus Plan.
The FCA notification in respect of the above made in accordance with the requirements of the UK Market Abuse Regulation, is appended below.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
| a) | Name | Ian Melling | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Chief Financial Officer | |||
| b) | Initial notification /Amendment | Initial Notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Victrex plc | |||
| b) | LEI | 213800UYNPHAUNHPXL67 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of 1p each | |||
| Identification code | GB0009292243 | ||||
| b) | Nature of the transaction | Exercise of 5,396 nil cost options, comprising of 2,282 options granted on 12 December 2022 under the Victrex plc 2009 Long Term Incentive Plan and 1,957 options granted on 12 December 2022 under the 2017 Deferred Bonus Plan. The options comprised of 1,157 shares being made up of a dividend equivalent amounts across the grants. Sold sufficient shares 2,546 arising from the exercise to cover costs and retained the balance of 2,850 as shares. |
|||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| £6.458 | 5,396 | ||||
| d) | Aggregated information | n/a single transaction | |||
| - Aggregated volume | |||||
| - Price | |||||
| e) | Date of the transaction | 2025-12-17 | |||
| f) | Place of the transaction | London Stock Exchange |
About Victrex:
Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy & Industrial, Electronics and Medical. Every day, millions of people rely on products or applications which contain our sustainable materials, from smartphones, aeroplanes and cars to energy operations and medical devices. With over 40 years' experience, we are moving beyond the polymer into semi-finished and finished products which shape future performance for our customers and our markets, enable environmental and societal benefit for our customers and drive value for our shareholders. Find out more at www.victrexplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFZMMZKNLGKZM
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.